المؤلفون: Warli SM, Warli MH, Prapiska FF

المصدر: Research and Reports in Urology, Vol Volume 15, Pp 149-155 (2023)

مصطلحات موضوعية: prostate cancer, psa, pca3, tmprss2:erg, urine biomarker, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/pca3-and-tmprss2-erg-urine-level-as-diagnostic-biomarker-of-prostate-c-peer-reviewed-fulltext-article-RRUTest; https://doaj.org/toc/2253-2447Test

الوصول الحر: https://doaj.org/article/0923d5c9ff0f40bca1f22f05c4220732Test

المؤلفون: Hashim, Dana, Gonzalez-Feliciano, Amparo, Ahearn, Thomas, Pettersson, Andreas, Barber, Lauren, Pernar, Claire, Ebot, Ericka, Finn, Stephen, Giovannucci, Edward, Lis, Rosina, Loda, Massimo, Parmigiani, Giovanni, Lotan, Tamara, Kantoff, Philip, Mucci, Lorelei, Graff, Rebecca, Isikbay, Masis

المصدر: International Journal of Cancer. 146(10)

مصطلحات موضوعية: PTEN, TMPRSS2:ERG, family history, molecular subtypes, prostate cancer, Adult, Aged, Biomarkers, Tumor, Cohort Studies, Genetic Predisposition to Disease, Humans, Incidence, Male, Middle Aged, PTEN Phosphohydrolase, Prostatic Neoplasms, Risk Factors, Transcriptional Regulator ERG

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/6wd6g9nsTest

المؤلفون: Massimo Lazzeri, Vittorio Fasulo, Giovanni Lughezzani, Alessio Benetti, Giulia Soldà, Rosanna Asselta, Ilaria De Simone, Marco Paciotti, Pier Paolo Avolio, Roberto Contieri, Cesare Saitta, Alberto Saita, Rodolfo Hurle, Giorgio Guazzoni, Nicolò Maria Buffi, Paolo Casale

المصدر: Frontiers in Oncology, Vol 12 (2022)

مصطلحات موضوعية: TMPRSS2:ERG, prostate cancer, mpMRI, microUS, gene fusion, translocation, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2022.968384/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/3f5639b2c6ff461882733bfdc2e0b549Test

المؤلفون: Arun Sinha, Praveen Sharma, Kamla Kant Shukla, Prasenjit Mitra, Sanjeev Misra

المصدر: Annals of the National Academy of Medical Sciences (India), Vol 57, Iss 03, Pp 93-101 (2021)

مصطلحات موضوعية: long noncoding rna, gene fusion products, prostate-specific antigen, mirna, tmprss2:erg, General works, R5-130.5, Science

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/0379-038XTest; https://doaj.org/toc/2454-5635Test

الوصول الحر: https://doaj.org/article/7d65e716d36d4b69b317003f4b1c29a4Test

المؤلفون: Graff, Rebecca E, Pettersson, Andreas, Lis, Rosina T, Ahearn, Thomas U, Markt, Sarah C, Wilson, Kathryn M, Rider, Jennifer R, Fiorentino, Michelangelo, Finn, Stephen, Kenfield, Stacey A, Loda, Massimo, Giovannucci, Edward L, Rosner, Bernard, Mucci, Lorelei A

المصدر: American Journal of Clinical Nutrition. 103(3)

مصطلحات موضوعية: Urologic Diseases, Cancer, Clinical Research, Prevention, Prostate Cancer, Aging, Adult, Antineoplastic Agents, Phytogenic, Antioxidants, Carotenoids, Diet, Feeding Behavior, Humans, Lycopene, Solanum lycopersicum, Male, Middle Aged, Oncogene Proteins, Fusion, Plant Extracts, Prostatic Neoplasms, Trans-Activators, Transcriptional Regulator ERG, ERG protein expression, TMPRSS2:ERG, lycopene, prostate cancer, tomato sauce, Engineering, Medical and Health Sciences, Nutrition & Dietetics

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/7jp6m5mrTest

المؤلفون: Doris Höflmayer, Carla Willich, Claudia Hube-Magg, Ronald Simon, Dagmar Lang, Emily Neubauer, Frank Jacobsen, Andrea Hinsch, Andreas M. Luebke, Marie Christina Tsourlakis, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Sarah Minner, Franziska Büscheck, Guido Sauter, Thorsten Schlomm, Stefan Steurer, Till S. Clauditz, Eike Burandt, Waldemar Wilczak, Christian Bernreuther

المصدر: Diagnostic Pathology, Vol 14, Iss 1, Pp 1-8 (2019)

مصطلحات موضوعية: SNW1, Prostate cancer, Prognosis, TMPRSS2:ERG, SKIP1, Pathology, RB1-214

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s13000-019-0810-8Test; https://doaj.org/toc/1746-1596Test

الوصول الحر: https://doaj.org/article/9a8826e35f6d42988b384f101624709eTest

المؤلفون: Kluth M, Volta H, Hussein M, Taskin B, Frogh S, Möller-Koop C, Büscheck F, Jacobsen F, Tsourlakis MC, Lübke AM, Hinsch A, Clauditz T, Graefen M, Heinzer H, Huland H, Minner S, Sauter G, Wilczak W, Schlomm T, Simon R

المصدر: Cancer Management and Research, Vol Volume 10, Pp 5909-5917 (2018)

مصطلحات موضوعية: 3p13 deletion, prostate cancer, heterogeneity, TMPRSS2:ERG fusion, tissue microarray, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/deletion-of-3p13-is-a-late-event-linked-to-progression-of-tmprss2erg-f-peer-reviewed-article-CMARTest; https://doaj.org/toc/1179-1322Test

الوصول الحر: https://doaj.org/article/9a267aee43fb4c788c1f52a2ef132b3cTest

المؤلفون: Giunchi, Francesca, Massari, Francesco, Altimari, Annalisa, Gruppioni, Elisa, Nobili, Elisabetta, Fiorentino, Michelangelo, Ardizzoni, Andrea

المساهمون: Giunchi, Francesca, Massari, Francesco, Altimari, Annalisa, Gruppioni, Elisa, Nobili, Elisabetta, Fiorentino, Michelangelo, Ardizzoni, Andrea

مصطلحات موضوعية: TMPRSS2:ERG fusion, lung cancer, next-generation sequencing, prostate cancer

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33419298; info:eu-repo/semantics/altIdentifier/wos/WOS:000601941100001; volume:10; issue:12; firstpage:1; lastpage:5; numberofpages:5; journal:DIAGNOSTICS; https://hdl.handle.net/11585/793501Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85109067235; https://www.mdpi.com/2075-4418/10/12/1109Test

الإتاحة: https://doi.org/10.3390/diagnostics10121109Test
https://hdl.handle.net/11585/793501Test
https://www.mdpi.com/2075-4418/10/12/1109Test

المؤلفون: Francesca Giunchi, Francesco Massari, Annalisa Altimari, Elisa Gruppioni, Elisabetta Nobili, Michelangelo Fiorentino, Andrea Ardizzoni

المصدر: Diagnostics; Volume 10; Issue 12; Pages: 1109

مصطلحات موضوعية: TMPRSS2:ERG fusion, prostate cancer, lung cancer, next-generation sequencing

وصف الملف: application/pdf

العلاقة: Pathology and Molecular Diagnostics; https://dx.doi.org/10.3390/diagnostics10121109Test

الإتاحة: https://doi.org/10.3390/diagnostics10121109Test

المؤلفون: A. Musaelyan A., V. Nazarov D., S. Lapin V., A. Boriskin G., S. Reva A., D. Lebedev G., V. Yakovlev D., D. Viktorov A., A. Toropovskiy N., V. Emanuel L., S. Al-Shukri Kh., S. Petrov B., А. Мусаелян А., В. Назаров Д., С. Лапин В., А. Борискин Г., С. Рева А., Д. Лебедев Г., В. Яковлев Д., Д. Викторов А., А. Тороповский Н., В. Эмануэль Л., С. Аль-Шукри Х., С. Петров Б.

المصدر: Cancer Urology; Том 16, № 2 (2020); 65-73 ; Онкоурология; Том 16, № 2 (2020); 65-73 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2020-16-2

مصطلحات موضوعية: prostate cancer, prostate cancer early detection, genetic marker of prostate cancer, PCA3, TMPRSS2:ERG, prostatic specific antigen, PSA derivatives, prostate health index, рак предстательной железы, диагностика рака предстательной железы, генетический маркер рака предстательной железы, TMPRSS2ERG, простатический специфический антиген, дериваты ПСА, индекс здоровья предстательной железы

وصف الملف: application/pdf

العلاقة: https://oncourology.abvpress.ru/oncur/article/view/1013/1175Test; Bray F., Ferlay J., Soerjomataram I. et al. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2018. DOI:10.3322/caac.21492.; Mottet N., Bellmunt J., Bolla M. et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2017;71(4):618—29. DOI:10.1016/j.eururo.2016.08.003.; Leyten G.H., Hessels D., Jannink S.A. et al. Prospective multicentre evaluation of PCA3 and TMPRSS2:ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer. Eur Urol 2014;65(3):534—42. DOI:10.1016/j.eururo.2012.11.014.; Hendriks R.J., Van Oort I.M., Schalken J.A. Blood-based and urinary prostate cancer biomarkers: A review and comparison of novel biomarkers for detection and treatment decisions. Prostate Cancer Prostatic Dis 2017;20(1):12—9. DOI:10.1038/pcan.2016.59.; Scattoni V., Lazzeri M., Lughezzani G. et al. Head-to-head comparison of prostate health index and urinary PCA3 for predicting cancer at initial or repeat biopsy. J Urol 2013;190(2):496—501. DOI:10.1016/j.juro.2013.02.3184.; Yang Z., Yu L., Wang Z. PCA3 and TMPRSS2:ERG gene fusions as diagnostic biomarkers for prostate cancer. Chinese J Cancer Res 2016;28(1):65—71. DOI:10.3978/j.issn.1000-9604.2016.01.05.; Zhou F., Gao S., Han D. et al. TMPRSS2:ERG activates NO-cGMP signaling in prostate cancer cells. Oncogene 2019;38(22):4397-411. DOI:10.1038/s41388-019-0730-9.; Martignano F., Rossi L., Maugeri A. et al. Urinary RNA-based biomarkers for prostate cancer detection. Clin Chim Acta 2017;473:96-105. DOI:10.1016/j.cca.2017.08.009.; Catalona W.J., Partin A.W., Sanda M.G. et al. A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J Urol 2011;185(5):1650-5. DOI:10.1016/j.juro.2010.12.032.; Koo K.M., Mainwaring P.N., Tomlins S.A., Trau M. Merging new-age biomarkers and nanodiagnostics for precision prostate cancer management. Nat Rev Urol 2019;16(5):302-17. DOI:10.1038/s41585-019-0178-2.; Carroll P.H., Mohler J.L. NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection. J Natl Compr Cancer Netw J Natl Compr Canc Netw 2018;16:620-3. DOI:10.6004/jnccn.2018.0036.; Cui Y., Cao W., Li Q. et al. Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis. Sci Rep 2016;6:25776. DOI:10.1038/srep25776.; Тороповский А.Н., Никитин А.Г., Гордиев М.Г и др. Результаты испытания набора реагентов для выявления мРНК гена РСА3 и определения уровня его экспрессии методом двустадийной ОТ-ПЦР-РВ (Проста-Тест) для диагностики рака предстательной железы in vitro в клинической практике. Вестник медицинского института «РЕАВИЗ» 2018;1:126-36.; Павлов К.А., Шкопоров А.Н., Хохлова Е.В. и др. Разработка диагностической тест-системы для ранней неинвазивной диагностики рака простаты, основанной на количественной детекции мРНК гена PCA3 в осадке мочи методом ОТ-ПЦР в режиме реального времени. Вестник РАМН 2013;(5):45—51.; Merola R., Tomao L., Antenucci A. et al. PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: A National Cancer Institute experience. J Exp Clin Cancer Res 2015;34(1):15. DOI:10.1186/s13046-015-0127-8.; Аполихин О.И., Сивков А.В., Ефремов ГД. и др. РСА3 и TMPRSS2:ERG в диагностике рака предстательной железы: первый опыт применения комбинации маркеров в России. Экспериментальная клиническая урология 2015;(2):30—5.; Park K., Dalton J.T., Narayanan R. et al. TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia. J Clin Oncol 2014;32(3):206-11. DOI:10.1200/JCO.2013.49.8386.; Wang Z., Wang Y., Zhang J. et al. Significance of the TMPRSS2:ERG gene fusion in prostate cancer. Mol Med Rep 2017;16(4):5450-8. DOI:10.3892/mmr.2017.7281.; Fujita K., Nonomura N. Urinary biomarkers of prostate cancer. Int J Urol 2018;25(9):770-9. DOI:10.1111/iju.13734.; Sanda M.G., Feng Z., Howard D.H. et al. Association between combined TMPRSS2:ERG and PCA3 RNA urinary testing and detection of aggressive prostate cancer. JAMA Oncol 2017;3(8):1085-93. DOI:10.1001/jamaoncol.2017.0177.; Van Hoof A., Bunn W., Klein A., Albala D. Role of molecular diagnostics in prostate cancer. Surg Proced Core Urol Trainees 2018:151-77. DOI:10.1007/978-3-319-57442-4_17.; Perdona S., Bruzzese D., Ferro M. et al. Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy. Prostate 2013;73(3):227-35. DOI:10.1002/pros.22561.; De la Calle C., Patil D., Wei J.T. et al. Multicenter evaluation of the prostate health index to detect aggressive prostate cancer in biopsy Naive men. J Urol 2015;194(1):65-72. DOI:10.1016/j.juro.2015.01.091.; https://oncourology.abvpress.ru/oncur/article/view/1013Test

الإتاحة: https://doi.org/10.17650/1726-9776-2020-16-2-65-73Test
https://doi.org/10.17650/1726-9776-2020-16-2Test
https://doi.org/10.3322/caac.21492Test
https://doi.org/10.1016/j.eururo.2016.08.003Test
https://doi.org/10.1016/j.eururo.2012.11.014Test
https://doi.org/10.1038/pcan.2016.59Test
https://doi.org/10.1016/j.juro.2013.02.3184Test
https://doi.org/10.3978/j.issn.1000-9604.2016.01.05Test
https://doi.org/10.1038/s41388-019-0730-9Test
https://doi.org/10.1016/j.cca.2017.08.009Test